These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 37553850)

  • 1. Integrative omics approaches to advance rare disease diagnostics.
    Smirnov D; Konstantinovskiy N; Prokisch H
    J Inherit Metab Dis; 2023 Sep; 46(5):824-838. PubMed ID: 37553850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A guide for the diagnosis of rare and undiagnosed disease: beyond the exome.
    Marwaha S; Knowles JW; Ashley EA
    Genome Med; 2022 Feb; 14(1):23. PubMed ID: 35220969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A scoping review and proposed workflow for multi-omic rare disease research.
    Kerr K; McAneney H; Smyth LJ; Bailie C; McKee S; McKnight AJ
    Orphanet J Rare Dis; 2020 Apr; 15(1):107. PubMed ID: 32345347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the Boundaries of RNA Sequencing as a Diagnostic Tool for Rare Mendelian Disease.
    Gonorazky HD; Naumenko S; Ramani AK; Nelakuditi V; Mashouri P; Wang P; Kao D; Ohri K; Viththiyapaskaran S; Tarnopolsky MA; Mathews KD; Moore SA; Osorio AN; Villanova D; Kemaladewi DU; Cohn RD; Brudno M; Dowling JJ
    Am J Hum Genet; 2019 Mar; 104(3):466-483. PubMed ID: 30827497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of transcriptome sequencing for rare Mendelian diseases.
    Lee H; Huang AY; Wang LK; Yoon AJ; Renteria G; Eskin A; Signer RH; Dorrani N; Nieves-Rodriguez S; Wan J; Douine ED; Woods JD; Dell'Angelica EC; Fogel BL; Martin MG; Butte MJ; Parker NH; Wang RT; Shieh PB; Wong DA; Gallant N; Singh KE; Tavyev Asher YJ; Sinsheimer JS; Krakow D; Loo SK; Allard P; Papp JC; ; Palmer CGS; Martinez-Agosto JA; Nelson SF
    Genet Med; 2020 Mar; 22(3):490-499. PubMed ID: 31607746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expanding diagnostic toolbox for rare genetic diseases.
    Kernohan KD; Boycott KM
    Nat Rev Genet; 2024 Jun; 25(6):401-415. PubMed ID: 38238519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosing rare diseases after the exome.
    Frésard L; Montgomery SB
    Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30559314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of genomics and metabolomics for prioritization of rare disease variants: a 2018 literature review.
    Graham E; Lee J; Price M; Tarailo-Graovac M; Matthews A; Engelke U; Tang J; Kluijtmans LAJ; Wevers RA; Wasserman WW; van Karnebeek CDM; Mostafavi S
    J Inherit Metab Dis; 2018 May; 41(3):435-445. PubMed ID: 29721916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype-aware prioritisation of rare Mendelian disease variants.
    Kelly C; Szabo A; Pontikos N; Arno G; Robinson PN; Jacobsen JOB; Smedley D; Cipriani V
    Trends Genet; 2022 Dec; 38(12):1271-1283. PubMed ID: 35934592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Developments and Possibilities in Reanalysis and Reinterpretation of Whole Exome Sequencing Datasets for Unsolved Rare Diseases Using Machine Learning Approaches.
    Setty ST; Scott-Boyer MP; Cuppens T; Droit A
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Has the Undiagnosed Diseases Network Taught Us About the Clinical Applications of Genomic Testing?
    Murdock DR; Rosenfeld JA; Lee B
    Annu Rev Med; 2022 Jan; 73():575-585. PubMed ID: 35084988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International Undiagnosed Diseases Programs (UDPs): components and outcomes.
    Curic E; Ewans L; Pysar R; Taylan F; Botto LD; Nordgren A; Gahl W; Palmer EE
    Orphanet J Rare Dis; 2023 Nov; 18(1):348. PubMed ID: 37946247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases.
    van Karnebeek CDM; O'Donnell-Luria A; Baynam G; Baudot A; Groza T; Jans JJM; Lassmann T; Letinturier MCV; Montgomery SB; Robinson PN; Sansen S; Mehrian-Shai R; Steward C; Kosaki K; Durao P; Sadikovic B
    Orphanet J Rare Dis; 2024 Sep; 19(1):357. PubMed ID: 39334316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome sequencing and implications for rare disorders.
    Posey JE
    Orphanet J Rare Dis; 2019 Jun; 14(1):153. PubMed ID: 31234920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of whole-exome sequencing in rare diseases: Galactosialidosis.
    Prada CE; Gonzaga-Jauregui C; Tannenbaum R; Penney S; Lupski JR; Hopkin RJ; Sutton VR
    Eur J Med Genet; 2014 Jul; 57(7):339-344. PubMed ID: 24769197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current genetic diagnostics in inborn errors of immunity.
    von Hardenberg S; Klefenz I; Steinemann D; Di Donato N; Baumann U; Auber B; Klemann C
    Front Pediatr; 2024; 12():1279112. PubMed ID: 38659694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long tail and rare disease research: the impact of next-generation sequencing for rare Mendelian disorders.
    Shen T; Lee A; Shen C; Lin CJ
    Genet Res (Camb); 2015 Sep; 97():e15. PubMed ID: 26365496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modern methods in diagnostics and research of molecular bases of rare diseases.
    Kmoch S; Zeman J
    Cas Lek Cesk; 2018; 157(3):133-136. PubMed ID: 30441942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.